|
Published by: Datamonitor
Published: Nov. 12, 2001 - 192 Pages
Table of Contents
DATAMONITOR HEALTHCARE
CONTACT DETAILS
EXECUTIVE SUMMARY
Scope
Datamonitor insight into the dermatology market
Key metrics
INTRODUCTION
Dermatitis
Disease Definition
Diagnosis of dermatitis
Risk factors
Treatment of dermatitis
Psoriasis
Disease Definition
Diagnosis of psoriasis
Risk factors
Treatment of psoriasis
Urticaria
Disease Definition
Acute Urticaria
Chronic Urticaria
Physical Urticaria
Diagnosis
Risk factors
Treatment of urticaria
Acne
Disease Definition
Diagnosis
Risk factors
Treatment of acne
TREATMENT PRACTICES
Psoriasis
Epidemiology
Treatment trees and patients flow
Presentation
Diagnosis
Treatment
Pharmacological therapy
Non pharmacological therapy
Unmet needs of treatment
Atopic dermatitis
Epidemiology
Treatment trees
Presentation
Diagnosis
Treatment
Pharmacological therapy
Topical therapy
Systemic therapy
Non pharmacological therapy
Phototherapy
Unmet needs of treatment
Acne
Epidemiology
Treatment trees
Presentation
Diagnosis
Treatment
Pharmacological therapy
Unmet needs of treatment
Urticaria (Hives)
Epidemiology
Treatment tree
Presentation
Diagnosis
Treatment
Pharmacological therapy
Non-pharmacological therapy
Unmet needs
MARKET ANALYSIS
Global market overview
Regional breakdown
Breakdown by indication
Global sales of selected dermatolgical products
Company strategy
Differentiation of new products
Case scenario
DTC advertising
Working with patients
Genomics
Pricing
Cross-indications
PIPELINE ANALYSIS
Dermatological Product Pipeline
Preclinical and phase I products
Phase II
Phase III and registration
Product by indication
Dermatitis
Registration phase
ASM 981
Psoriasis
Phase III
Amevive (alefacept)
OLUX (clobetasol propionate)
Xanelim
Phase II
Neovastat (psovascar)
Nuvion (anti-CD3 mAb)
Zenepax (daclizumab)
CTLA-4Ig
IDEC-114/anti B7-1
IDEC 131/anti-CD40L
ISIS 104838
ISIS 2302
Paclitaxel
ABX-IL8
Ontak (denileukin difitox)
Targretin (bexarotene)
Siplizumab (MEDI 507)
Enbrel (etanercept)
PVACTM
Urticaria
HCT 1026 (flurbiprofen)
ACNE
Artisone
MARKET FORECAST
Dermatology Market Forecasts (2001-2008)
Forecast per indication
Events impacting the dermatology market
Increasing prevalence
Increased awareness, presentation rates and levels of drug treatment
Rotation/combination therapies
Entry of new drugs
Major patent expiries
Pricing
Selected dermatological forecasts (2001-2008)
Psoriasis
Atopic dermatitis
Acne
APPENDIX
Datamonitor's Immune Disorders and Inflammation Business Unit
Contributing experts
Clinical Trial Data Bibliography and Other References
Physician research methodology
Introduction
Hypothesis formulation
Physician recruitment
Hypothesis testing
Validation and quality control
Sales data research methodology
Introduction
Hypothesis formulation
Hypothesis testing
Data verification with key contacts
Quality control
Quantification of data reliability
Confidence ratings
R&D research methodology
Introduction
Hypothesis formulation
Hypothesis testing
Data verification and quality control
Quantification of data reliability
Forecast Methodology
Predicting market share
Forecasting future growth
Market growth
Drug class growth
Individual drug growth
Forecasting Drug Launches for Drugs in Development
Global highest stage of development
Reclassification of development phases
Probability of a product progressing to launch
List of Tables
List of Figures
AbstractThis report focuses on the market for four dermatological disorders, namely psoriasis, dermatitis, acne and urticaria. It describes the current and future trends in the treatment of these diseases, and highlights the key unmet needs and opportunities in this market for the period 2001-2007.
Get Full Details About This Report >>
|
